However, whether the strategy of blocking TREM2 in GBM cells can turn the immunologically “cold” GBM into hot one and reverse the radioresistance of GBM cells, as well as the specific molecular mechanisms involved are still unclear now. This evidence concerns the gene TREM2 and glioblastoma.